No Early Relief for JW Therapeutics from Cancer Wonder Drug 「抗癌神藥」營收有限 藥明巨諾虧損擴大
The biotech company logs revenue of 66 million yuan from its cutting-edge cancer therapy, but losses jump more than 50% to nearly 430 million yuan 這家生物科技公司旗下的「抗癌神藥」去年僅錄得6,600萬元收入，虧損額增加一半至4.3億元。
Bamboo Works (official website) provides news on Chinese companies listed in Hong Kong and the United States, with a strong focus on mid-cap and also pre-IPO companies.